Welcome
COVID-19 continues to pose a significant risk to older adults and people with chronic health conditions. Timely identification, diagnosis, and treatment can substantially improve patient outcomes, yet many eligible patients still miss opportunities for early intervention.
This free, self-paced course has been designed for busy healthcare professionals. Across five short modules (10–15 minutes each), you’ll gain practical, evidence-based strategies to improve the care of patients at high risk of severe COVID-19.
Developed by an international team of clinicians, behavioural scientists, and researchers, the course combines current clinical evidence with behavioural science tools to support effective communication, address treatment hesitancy, and provide culturally appropriate, person-centred care.
Before you begin, please complete the short pre-course assessment using the button below. After completing all five modules, we ask you to complete the post-course assessment to help us evaluate the course, improve future training, and download your Certificate of Completion. Both assessments take only a few minutes to complete.
Each module includes practical examples and downloadable resources to support learning and implementation in clinical practice.
Why shall I complete this training?
This course equips healthcare professionals with practical skills that extend beyond COVID-19, making it highly relevant across a range of diseases and high-risk patient populations.
1. Risk stratification and early intervention
Learn to identify high-risk patients, assess eligibility for treatment, and prioritise timely intervention.
These skills are directly applicable to other infectious diseases (e.g., influenza, RSV) and chronic conditions where early detection improves outcomes.
2. Behavioural science and patient engagement
Apply behaviour change techniques to address patient hesitancy, misconceptions, or low adherence.
Develop skills in culturally and linguistically appropriate communication, useful across all clinical contexts.
3. Clinical decision-making frameworks
Use case-based scenarios to develop structured reasoning and guideline-based decision-making.
These approaches are transferable to managing conditions such as atrial fibrillation, diabetes, and COPD exacerbations.
4. Digital and microlearning delivery
The modular, self-paced format, including online case scenarios and practical tools, can be adapted for other diseases or professional development initiatives.
5. Evaluation and reflective practice
Pre- and post-training assessments support self-reflection and continuous learning, applicable to any clinical topic or training programme.
Modules
Czy pacjenci z grupy wysokiego ryzyka są rozpoznawani na czas? Wczesna identyfikacja COVID-19 w praktyce klinicznej
Autorzy: Astin Sokang (Universitas Kristen Krida Wacana, Indonezja); Triana Kesuma Dewi (Universitas Airlangga, Indonezja); Yuhang Zhu (Shandong Second Medical University, Chiny); Gill ten Hoor (Maastricht University, Holandia) U wielu osób dorosłych COVID-19 ma...
Szybkie działanie, lepsze wyniki: znaczenie wczesnej interwencji w COVID-19 u pacjentów z grupy wysokiego ryzyka
Autorzy: İrem Berna Güvenç Erdoğan (Middle East Technical University, Turcja); Iga Palacz-Poborczyk (SWPS University, Polska); Olga Perski (Stockholm University, Szwecja); Sheson Tiwari (Psyfolks Education, Indie); Belgin Ünal (University of Michigan, USA) Przebieg...
Zapobieganie powikłaniom COVID-19 u pacjentów z grupy wysokiego ryzyka poprzez zmianę zachowania
Autorzy: David Simons (Pennsylvania State University, USA); Ayşegül Bakır (Hacettepe University, Turcja); Johanna Nurmi (University of Helsinki, Finlandia) COVID-19 bywa zwykle opisywany w czasie przeszłym i wyłącznie jako infekcja układu oddechowego. Tymczasem...
Życie po COVID-19: Jak zarządzać długofalowymi skutkami zdrowotnymi?
Autorki: Dominika Kwasnicka (University of Melbourne) oraz Rizmina Rilwan (niezależna badaczka, Sri Lanka) Pacjent po ostrej fazie COVID-19. Czego wciąż się uczymy? Ostra faza pandemii już za nami, ale w gabinetach lekarskich coraz częściej widzimy jej długofalowe...
Jak nauki o zachowaniu mogą wesprzeć diagnozę i leczenie COVID-19 w grupach wysokiego ryzyka
Autorki: Tracy Epton (Uniwersytet w Manchesterze, Wielka Brytania), Lisa Marie Warner (Szkoła Medyczna MSB w Berlinie, Niemcy) oraz Aleksandra Lazic (niezależna badaczka z Belgradu, Serbia) Praca z pacjentami z grup wysokiego ryzyka w kontekście COVID-19 może...